|
|
|
By Matthew Pillar, editor, Bioprocess Online | Want to ensure you've got your biotech legal, IP, and patent bases covered? Join Business of Biotech host Matt Pillar and BlueSphere Bio CEO and biotech legal expert Keir LoIacono on 11/13 for the live, interactive, and FREE digital event, Legal And IP Protection For New Biotechs. |
|
|
|
By Tim Sandle, Ph.D. | The new ISO 14644 Part 21 addresses optimizing particle counter accuracy in cleanrooms, focusing on reducing sampling error and particle loss. Discussion includes the use of airborne particle counters, tubing, and isokinetic probes. |
|
|
|
By Sampatkumarr Govind Donthula, MarketsandMarkets | The active pharmaceutical ingredient (API) market is estimated at $158 billion in 2023 and is projected to reach $232 billion by 2028. This article shares new market research on APIs, including an analysis of innovative and generic APIs, synthetic and biotech APIs, and more. |
|
|
|
By Lorraine Mackiewicz, Clarkston Consulting | If you're a precommercial biopharma looking ahead to commercial stage, evaluating partnerships is faced with making key decisions around which capabilities to outsource, the degree of data access and ownership, and which external partners are the right fit. Here are four key actions to consider. |
|
|
|
|
|
|
|
|
|
|
|
|
LIFE SCIENCE LEADER MAGAZINE |
|
|
|
Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business. |
|
|
